In contrast to the results observed after IGF1R abrogation in EpCAMhigh cancer cells, loss of IGF1R signaling in EpCAMlow cancer cells did not affect the ability of these hybrid cancer cells to generate mesenchymal cSCCs (Fig. S7C). This evidence concerns the gene IGF1R and cancer.